Revenue segments as reported by the company.

Clearing and transaction fees

Market data and information services

Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Compensation and benefits  

Technology

Professional fees and outside services

Amortization of purchased intangibles

Depreciation and amortization

Licensing and other fee agreements

Other expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CME Group achieves record-breaking 2022 performance amidst market challenges

CME Group's 2022 performance was exceptional, marked by record volumes, revenue growth, and successful transitions. The company's focus on innovation, strategic positioning in energy and cryptocurrency markets, and pricing adjustments have driven positive outcomes. Challenges in margins and market uncertainties require careful navigation.

CME Group posts record Q1 earnings, eyes growth in SOFR

CME Group delivered a strong performance in Q1 2023, achieving record revenue and profitability driven by growth in interest rate and options trading.
The company's strategic focus on risk management, shareholder value creation, and market competitiveness positions it well for future growth and revenue generation.
While facing challenges in a competitive market environment, CME Group has opportunities to capitalize on the demand for SOFR products and options trading.
Optimism surrounding the company's future growth potential, coupled with effective expense management and revenue diversification, underpin its resilience and strategic outlook.

CME Group excels in Q2 with record revenue and strategic focus

CME Group's Q2 earnings call showcased strong financial performance, driven by growth across asset classes and a focus on customer-centric strategies. The company's emphasis on innovation, regulatory compliance, and market leadership positions it well for future growth.

CME Group reports strong Q3 earnings, eyes growth amid challenges

CME Group's Q3 2023 earnings call highlighted robust financial performance, operational efficiency, and strategic positioning. Despite facing regulatory challenges and cost management concerns, the company remains confident in its offerings and growth prospects. Opportunities for expansion through innovation and capitalizing on market trends were key discussion points.

CME Group achieves record 2023 results amidst global uncertainties

CME Group's record-breaking performance in 2023 underscores its market leadership and financial strength, with revenue growth, margin expansion, and strong product demand driving positive results.
While facing challenges from global uncertainties and market dynamics, the company's strategic focus on innovation, risk management, and efficiency positions it well to capitalize on opportunities in evolving markets.
By introducing new products, expanding partnerships, and navigating changing market conditions adeptly, CME Group demonstrates resilience and adaptability, paving the way for continued growth and success in the financial industry.
Overall, CME Group's strategic initiatives, financial performance, and market positioning reflect a company poised for sustained success, leveraging opportunities and strengths to overcome challenges and drive future growth.

CME Group achieves record earnings in Q1 2024, eyes growth

CME Group delivered a strong performance in Q1 2024, setting records in revenue and earnings.
The company faces challenges in managing expenses amid growth initiatives and competitive dynamics.
However, CME's strengths in market leadership, network infrastructure, and regulatory alignment position it well for future opportunities.
By capitalizing on data services and revenue growth avenues, CME can continue its upward trajectory in the market.

CME Group achieves record Q3 performance amidst regulatory challenges

CME Group's Q3 performance was exceptional, marked by record volumes and financial metrics. Despite challenges in regulatory compliance and competition, the company is well-positioned for growth through strategic opportunities in interest rate products and retail expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CHICAGO, Feb. 9, 2022 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the fourth quarter and full year of 2021. The company reported revenue of $1.1 billion and operating income of $632 million for the fourth quarter of 2021.

CME Group Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results

CME Group (CME) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Earnings Season Could Be Great for CME Group (CME)

CHICAGO, Feb. 8, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced it will launch CBL Core Global Emissions Offset™ (C-GEO™) futures on March 7, 2022, pending all relevant regulatory reviews. CBL C-GEO futures are intended to align with the Core Carbon Principles, an emerging set of transparent and consistent standards around the supply of carbon credits to be overseen by the Integrity Council for the Voluntary Carbon Markets.

CME Group to Launch CBL Core Global Emissions Offset Futures

CME Group is scheduled to report its fiscal Q4 2021 results on Wednesday, February 9, 2022. We expect CME Group's revenues to be in line (just below) with the consensus estimates, while the earnings will likely miss the mark.

CME Group Stock To Miss The Earnings Consensus In Q4?

Above $230, CME has broken out of a consolidation that started with its $224 - $225 highs in February '20. CME is one of the ultimate "uncorrelated" stocks: it tends to do better in volatile, low-return markets like the 2000s.

CME Earnings Preview: Technical Breakout On The Stock, Fundamentals Need To Follow

Robinhood

Charles Schwab

As we look around to try to work out who is going to benefit from rising interest rates, think of brokers. Financial market brokers, Robinhood, Schwab, CME Group, the market structure is such that they will benefit.

Companies That Benefit From Rising Interest Rates - Brokers

ConocoPhillips

Thirty-three S&P 500 companies lifted dividends in January, the same number as a year ago. Some raised payouts dramatically, like Tractor Supply.

ConocoPhillips, CME Group and Others Boosted Dividends

mmary CME Group is a Dividend Challenger with a 12 year streak of increasing dividends. Shares currently offer a forward dividend yield of 1.66%. CME Group announced an 11% dividend increase yesterday increasing the quarterly payout to $1.00 per share.

CME Group: A Financial Intermediary With De Facto Monopolies

CME Group's (CME) fourth-quarter performance is likely to have been aided increased trading activity and lower costs.

What's in the Cards for CME Group (CME) in Q4 Earnings?

CHICAGO, Feb. 2, 2022 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its January 2022 market statistics, showing average daily volume (ADV) increased 28% to 24.6 million contracts during the month. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume.

CME Group Reports January 2022 Monthly Market Statistics

Chevron

Altria

S&P Global

Retirement can be a difficult period for most people because of the lack of a paycheck. Investing in quality companies can help ameliorate the pain of other illiquid assets.

4 best retirement stocks as the Fed prepares to hike rates

NEW YORK--(BUSINESS WIRE)---- $CME #NYTop100--Newman Ferrara LLP Announces Corporate Governance Investigation of CME Group Inc.

Newman Ferrara LLP Announces Corporate Governance Investigation of CME Group Inc. – CME

CHICAGO , Jan. 25, 2022 /PRNewswire/ -- CME Group ,  the world's leading and most diverse derivatives marketplace, today announced that its Equity Index futures and options complex reached a new, single-day trading volume record of 15,846,802 contracts on January 24, surpassing the prior record of 15,623,428 contracts set on February 28, 2020. Additionally, Micro E-mini Equity Index futures reached a record 6,571,375 contracts traded on January 24, across all four indices – S&P 500, Nasdaq-100, Dow Jones Industrial Average and Russell 2000.

CME Group Announces Multiple Equity Index Futures and Options Records

Cboe Global Markets

Securities Exchanges Benefitting From Market Volatility

Coinbase

Shopify

Silvergate Capital Corp

Block

Could blockchain stocks benefit from the rising adoption of cryptocurrencies?

5 Top Blockchain Stocks To Watch In January 2022

Few companies benefit from rising rates, but this one does.

Why Rising Interest Rates Are Good News for CME Group

Equity Residential

Realty Income Corp

Weyerhaeuser

These stocks should benefit from inflation.

4 of the Safest High-Yield Dividend Stocks on the Planet

SINGAPORE , Jan. 12, 2022 /PRNewswire/ -- CME Group , the world's leading and most diverse derivatives marketplace, today announced that its two new China portside iron ore futures contracts have launched and are available for trading. A total of 500 contracts have traded since launching on January 10, with participation from a number of firms, including ForChi Holding Pte Ltd, Theme International Trading and Trafigura.

CME Group Announces First Trades of China Portside Iron Ore Futures

LONDON and SINGAPORE , Jan. 11, 2022 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today announced that it achieved record international average daily volume (ADV) of 5.5 million contracts in 2021, up 4% from 2020. This record, reflecting all trading done outside the United States, was driven largely by growth in Interest Rate products, up 19%.

CME Group Achieves Record International Average Daily Volume of 5.5 Million Contracts in 2021, Up 4% from 2020

CHICAGO, Jan. 10, 2022 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today announced it will expand its benchmark U.S. Treasury futures and options offering with the addition of 20-Year U.S. Treasury Bond futures on March 7, pending regulatory review. The new 20-Year U.S. Treasury Bond futures will allow for delivery of original issue 20-year U.S. Treasury bonds with remaining terms to maturity at delivery of at least 19 years 2 months and not more than 20 years.

CME Group to Launch 20-Year U.S. Treasury Bond Futures on March 7

CME Group (CME) reported record volumes for the fourth quarter as well as full-year 2021.

CME Group (CME) December ADV Up Y/Y, Q4 & 2021 ADV Robust

CHICAGO, Jan. 4, 2022 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today reported its full-year, Q4 and December 2021 market statistics, showing it reached a record average daily volume (ADV) of 19.6 million contracts during the year, an increase of 3% over 2020. ADV increased 26% in both the fourth quarter and the month of December, to 20.5 million contracts and 18 million contracts, respectively.

CME Group Reports 2021 Annual, Q4 and Monthly Market Statistics

Compelling derivative product lines, global presence, a growing proportion of volume from customers outside the United States, focus on over-the-counter clearing services and effective capital deployment continue to drive CME Group (CME).

CME Group (CME) Rallies 24% YTD: More Room for Upside Left?

Air Products and Chemicals

Broadcom

Bank of Nova Scotia

Cardinal Health

Illinois Tool Works

Main Street Capital

Medtronic

McCormick

Nucor

Philip Morris

SPDR S&P 500 ETF Trust

Stryker

W. P. Carey

Xcel Energy

We provide a summary of upcoming ex-dividend dates in a quick reference table. The table includes relevant data and key statistics as well as the next payout and pay date.

Upcoming Ex-Dividend Dates: December 21-January 3, 2021

CME Group stock has gained 26% YTD, and at its current price of $229 per share, it is trading at the same level as the fair value of $229 – Trefis' estimate for CME Group's valuation. The exchange posted better than expected results in the third quarter of 2021, with net revenues increasing 3% yoy.

News for CME Group Stock (CME)